About this trial
Peripheral arterial disease (PAD) affects over 200 million people worldwide and is caused by narrowing of the arteries. Intermittent claudication, characterized by pain when walking, is its main symptom. Despite the proven benefits of exercise, there is no optimal protocol for treatment. To analyze the effects of different exercise conditions on proteomic and physiological markers in patients with PAD and to determine their preferences regarding exercise conditions. A clinical cross-over study with four randomized experimental conditions (aerobic training, traditional strength training, circuit training and control) will be conducted. Patients with grade IIa-IIb PAD according to the Leriche-Le Fontaine scale will be recruited from the Department of Angiology and Vascular Surgery Department of the Hospital Clínico Universitario de Valladolid. In each experimental session, measurements of cardiorespiratory capacity, post-exercise oxygen debt, ankle-brachial index, blood flow, peripheral oxygen saturation, perceived exertion, heart rate variability and blood proteome changes will be performed.
Eligibility criteria
Qualifiers
Be 18 years of age or older.
Patients diagnosed with peripheral arterial disease at grade IIa or IIb according to the Leriche-Fontaine classification.
Disqualifiers
Patients with dementia or cognitive impairment.
Patients with recent major surgery (≤12 months) or lower limb amputations.
Patients institutionalized in healthcare facilities.
Patients dependent on a wheelchair.
Trial design
Treatments tested in this trial
- Aerobic exercise
- Traditional strength exercise
- Circuit strength exercise
Treatment groups
Locations
Sponsors and collaborators
European University Miguel de Cervantes
Lead sponsor
Hospital Clínico Universitario de Valladolid. Angiology and Vascular Surgery Department.
Collaborator